Health Condition 1: K135- Oral submucous fibrosis
Conditions
Interventions
Intervention1: Pirfenidone Drug: Pirfenidone Drug 200mg thrice daily for 21 days
Control Intervention1: NIL: NIL
Sponsors
Dr Akshaya S R
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female and male with positive history of areca nut chewing in any form 2. Patients with clinically diagnosed Oral submucous fibrosis 3. Patients those who are willing to take part in the study
Exclusion criteria
Exclusion criteria: 1. Patient with systemic disorders such as uncontrolled diabetes, Systemic hypertension, cardiac illness, liver disease, bleeding disorder, gastrointestinal disorder and renal disease. 2. Patients with TMJ disorders and other forms of trismus are excluded from the study 3. Those who had received previous treatment were excluded from the study 4. Patients who is under Fluvoxamine and ciprofloxacin are not included in the study 5.Patients who are smoking are not included in the study 6. Patients not willing to give up addiction habits of Gutka, Pan-Masala, tobacco, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Burning sensation is recorded using a visual analog scale. Timepoint: 21 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Mouth opening (Inter incisal distance) scoring was adoptedTimepoint: 21 days | — |
Countries
India
Contacts
Public ContactDr Akshaya S R
Tamilnadu Dr. MGR medical university
Outcome results
None listed